Comparison of serum malondialdehyde levels determined by two different methods in patients with COPD: HPLC or TBARS methods

Laboratory Medicine

Volumn 36, Issue 1, 2005, Pages 41-44

  Tug, Tuncer ^a   Karatas, Fikret ^a   Terzi, Selim Murat ^a   Ozdemir, Necmi ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

MALONALDEHYDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; AGED; ARTERIAL GAS; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTERMETHOD COMPARISON; MALE; SENSITIVITY AND SENSIBILITY; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY;

EID: 11344285902     PISSN: 00075027     EISSN: None     Source Type: Journal    
DOI: 10.1309/WTEET9TJ2LUMB3C3     Document Type: Article

References (22)

1. Global Initiative for Chronic Obstructive Lung Disease. NHLBI/WHO Workshop Report. National Institutes of Health. 2001. Publication number: 2701.
2. Sahin U, Unlu M, Ozguner F, et al. Lipid peroxidation and glutathione peroxidase activity in chronic obstructive pulmonary disease exacerbation: prognostic value of malondialdehyde. J Basic Clin Physiol Pharmacol. 2001;12: 59-68.
3. Halliwell B. Free radical antioxidants in human disease. Curiosity, cause or consequence. Lancet. 1994;344:721-724.
4. Gotz ME, Freyberger A and Riederer V. Oxidative stress - A role in the pathogenesis of Parkinsons disease. J Neural Transmission. 1990;S29:241-249.
5. Rahman I, Swarska E, Henry M, et al. Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease? Thorax. 2000;55:189-193.
6. Dekhuinjzen PNR, Aben KKH, Dekker I, et al. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996;154:813-816.
7. Draper HH, Squites EJ, Mahmoodi H, et al. A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Radic Biol Med. 1993;15:353-363.
8. Karatas F, Karatepe M, Baysar A. Determination of free malondialdehyde in human serum by high performance liquid chromatography. Anal Biochem. 2002;311:76-79.
9. John LZ, Sorenson RJ. Formation of Cu or Fe thiobarbiturate complexes interfere with the determination of malondialdehyde. J Inorg Biochem. 1998;72:217-225.
10. Woisetschläger OE, Sünkel K, Weigand W, et al. Metal complexes of biologically important ligands, CXVI. Addition of carbanions from barbituric acid derivatives to unsaturated hydrocarbons in cationic complexes for the organometallic labelling of barbituric acid. J Organometallic Chem. 1999;584:122-130.
11. Yagi K. Assay of blood plasma or serum. Methods Enzymol. 1984;109:328-331.
12. Repine JE, Bast A, Lankhorst I. The oxidative stress study group. Oxidative stress in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1997;156:341-357.
13. McCord JM. Mechanism of diseases, oxygen-derived free radicals in post ischemic tissue injury. New Eng J Med. 1985;312:159-163.
14. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynoneal, malonaldehyde and related aldehydes. Free Rad Biol Med. 1991;11:81-128.
15. Kishida E, Kamura A, Tokumaru S, et al. Comparison of the formation of malondialdeyhde and thiobarbituric acid-reactive substance from autoxidized fatty acids based on oxygen consumption. J Agric Food Chem. 1993;41:1598-1600.
16. Zaki ZM, Mohamed GG. Spectral and thermal studies of thiobarbituric acid complexes. Spectrochimica Acta Part A. 2000;56:1245-1250.
17. Knight JA, Pieper RK,McClellan L. Specifity of the thiobarbituric acid teaction: Its use in studies of lipid peroxidation. Clin Chem. 1988;34:2433-2438.
18. Gelvan D, Saltman P. Different cellular targets for Cu- and Fe-catalyzed oxidation observed using a Cu-compatible thiobatbituric acid assay. Biochim Biophys Acta. 1990;1035:353-360.
19. MacNee W. Oxidants-antioxidants and COPD. Chest. 2000;117:303-317.
20. Steghens J, Van Kappel AL, Denis I, et al. Diaminonaphtalane, a new highly specific regent for HPLC-UV measurement of total and free malondialdehyde in human plasma or serum. Free Radic Biol Med. 2001;31:242-249.
21. Hultqvist M, Hegbrant J, Nilson CT, et al. Plasma concentrations of vitamin C, vitamin E, and/or malondialdehyde as markers of oxygen free radical production during hemodialysis. Clin Nephro. 1997;47:37-46.
22. Rahman I, Swarska E, MacNee W. Attenuation of oxidant/antioxidant imbalance during treatment of exacerbations of chronic obstructive pulmonary disease. Thorax. 1997;52:565-568.